What is HTFL's last price and market cap on Chartloom?

The overview shows a last price near n/a and market cap near 4.44B (subject to data latency), alongside the price snapshot and profile on this page.

What P/E and 52-week range are shown for HTFL?

P/E (TTM) is n/a and 52-week range is $20.13 to $54.32 when available from the data feed; see the metrics and chart on this page.

Where do Chartloom’s HTFL figures come from?

Figures are compiled from market data and SEC-backed fundamentals used in the app. Use primary filings and a broker for trading decisions.

What trailing-twelve-month financials does Chartloom show for HTFL?

The company profile lists revenue (TTM) near $212M, net income (TTM) near -$11.82B, EPS (TTM) near -$1.82 when available from the market-data feed. Figures are informational and may lag live markets.

Where is Heartflow Inc based, and what identifiers does Chartloom list?

The company context section lists headquarters in Mountain View, California, US, 86.2M shares outstanding, ISIN US42238D1072 when available from company profile and filing metadata.

Heartflow Inc

$HTFL

Health Care · Health Care Technology

Run Scenarios

Browse other companiesFree AI scores and summaries for more stocks

Heartflow Inc

$HTFL

Health Care · Health Care Technology

Run Scenarios

Overview AI Summary Charts Financials Valuation

Profile

Read AI summary

HeartFlow, Inc. operates as a cardiovascular company which engages in diagnosing coronary artery diseases. The company is headquartered in Mountain View, California and currently employs 843 full-time employees. The company went IPO on 2025-08-08. The Company’s novel HeartFlow Platform uses AI and advanced computational fluid dynamics to create a personalized three-dimensional (3D) model of a patient’s heart based on a single coronary computed tomography angiography (CCTA). Its AI-driven platform includes Roadmap Analysis, FFRCT Analysis and Plaque Analysis. The HeartFlow FFRCT Analysis and Plaque Analysis software assists physicians in diagnosing, managing and delivering precision care to patients with CAD. The RoadMap Analysis offers a highly intuitive anatomic visualization of the coronary arteries, helping physicians quickly identify clinically relevant areas to focus their review.

Employees

843

Website

www.heartflow.com/

IPO

2025-08-08

Beta

Next earnings date

—

Financials & valuation

Open valuation

Revenue (TTM)

Net income (TTM)

EPS (TTM)

P/E (price / listing EPS)

P/S (TTM)

Forward P/E

Forward P/S

EV / EBITDA

PEG (TTM)

FCF yield (TTM)

Gross margin (TTM)

Net margin (TTM)

Forward revenue growth (NTM)

Dividend / share (TTM)

Dividend yield (TTM)

Payout ratio (TTM)

Dividend growth (5Y)

Company context

Exchange

NASDAQ NMS - GLOBAL MARKET

ISIN

US42238D1072

Headquarters

Mountain View, California, US

Shares outstanding

86.2M

NAICS sector

Information

Institutional ownership

91.79%

Browse other companiesFree AI scores and summaries for more stocks

Overview AI Summary Charts Financials Valuation

Profile

Read AI summary

HeartFlow, Inc. operates as a cardiovascular company which engages in diagnosing coronary artery diseases. The company is headquartered in Mountain View, California and currently employs 843 full-time employees. The company went IPO on 2025-08-08. The Company’s novel HeartFlow Platform uses AI and advanced computational fluid dynamics to create a personalized three-dimensional (3D) model of a patient’s heart based on a single coronary computed tomography angiography (CCTA). Its AI-driven platform includes Roadmap Analysis, FFRCT Analysis and Plaque Analysis. The HeartFlow FFRCT Analysis and Plaque Analysis software assists physicians in diagnosing, managing and delivering precision care to patients with CAD. The RoadMap Analysis offers a highly intuitive anatomic visualization of the coronary arteries, helping physicians quickly identify clinically relevant areas to focus their review.

Employees

843

Website

www.heartflow.com/

IPO

2025-08-08

Beta

Next earnings date

—

Financials & valuation

Open valuation

Revenue (TTM)